1.8 million tons/year
Time of Update: 2022-08-27
8 million tons/year MDI technical renovation project•Project address: Existing factory at No. 39 Huandao North Road, Daxie Development Zone, Ningbo•Total investment: The investment amount of the MDI/HDI technical transformation and expansion integration project is 3220.
[JMC] You Qidong/Wang Lei, etc.: Research progress of small molecule targeting serine protein phosphatase (PPPases
Time of Update: 2021-08-08
Although they play a common mechanism of dephosphorylation through highly conserved catalytic active sites, different pppases show specificity according to their different regulatory subunits or unique structural features, which provides potential for the rational design of small molecules.
Cell: The new crown vaccine has a long way to go: a variety of COVID-19 variants evade neutralization through vaccine-induced humoral immunity
Time of Update: 2021-03-30
The mutations of the spike protein sequence of the following SARS-CoV-2 variant strains are as follows: wild type (Gray ) , D614G ( pink ) , B.
Don't pick wild mushrooms on the side of the road? But this kind of mushroom is "sweet", is it right to fight cancer and control sugar
Time of Update: 2021-03-27
Another study published in the Journal of Functional Foods showed that eating white mushrooms can produce subtle changes in the microbial community in the intestines, thereby improving the regulation of glucose in the liver.
Orphan Drug Weekly | Selective IL-2 agonists and other 4 research therapies are shortlisted
Time of Update: 2021-03-21
Drug: Nemvaleukin alfaR&D company: AlkermesTreatment of disease: mucosal melanoma (mucosal melanoma)Introduction: Nemvaleukin alfa is an innovative engineering fusion protein under research, which is composed of modified interleukin-2 (IL-2) and a high-affinity IL-2α receptor chain, designed to selectively amplify tumor-killing effects Immune cells, while avoiding activating immunosuppressive cells.
New research could increase the capacity of microbial "cell factories
Time of Update: 2021-03-16
An international team recently successfully analyzed the characteristics of different "production lines" in the "cell factory" to help increase the production capacity of microorganisms.
coli and yeast, two common "cell factories", and found that they had different production paths, such as different "production lines", when producing the energy molecule adenosine triphosphate.
Sales of the top 10 new drugs approved by the FDA are expected to peak at $16 billion in 2020
Time of Update: 2021-01-19
2020 is a special year for drug regulatory approval. In part because the ongoing COVID-19 pandemic has delayed many clinical trials, but also because some highly anticipated drug applications have bee
IBD: The condition is more severe in patients with inflammatory bowel disease that is combined with diabetes
Time of Update: 2020-09-24
, this study analyzed the severity of the disease in patients with IBD who had DM coexisting.
researchers say that patients with combined DM in IBD may be associated with an increase in the severity of the disease.
Innovative oral yew alcohol formula is eligible for FDA priority review for the treatment of metastasis breast cancer
Time of Update: 2020-09-19
formulation developed by Athenex is composed of yew alcohol and the new P-glycoprotein (P-gp) inhibitor encequidar.
it aims to compare the safety and effectiveness of oral yew alcohol monodrive therapy with intravenous yew alcohol monotherapy for metastasis breast cancer patients.
Lancet Rheumatol: The effect of Tocilizumab therapy on prognosis in patients with COVID-19 in intensive care units
Time of Update: 2020-09-01
study was conducted to study the correlation between hospitalization-related mortality in patients with TOcilizumab exposure and life-supporting COVID-19 dependent on ICU.
: In this observational study, the mortality rate of patients receiving tocilizum treatment coVID-19, which required ICU support, decreased.
"One week Jun" 18 pharmaceutical companies among the Fortune China 500; anti-tumor drug shuffling; the United States to support Kodak to compete for raw materials, intended to bring back
Time of Update: 2020-08-18
With the increase of cancer incidence in China, the reform of the drug regulatory review and approval system has further promoted the market of innovative drug research and development, and the cancer innovation drug has become a hot area of heavy investment of pharmaceutical companies.
How can DRGs point pay-as-you-go Zhejiang pharmaceutical companies adapt to the new situation of medical insurance control fees
Time of Update: 2020-07-09
Since the National Health Care Administration decided in May last year to carry out pilot work in 30 cities across the country on the pilot work of DRGs paying for disease diagnosis-related sub-grou
Scientists discover double-sided genes that are both cancer-and-cancer and cancer-causing
Time of Update: 2020-07-05
scientists have found a gene that helps mice protect themselves from of intestinal tumors, but the gene may also increase the risk of breast cancer spreading The discovery of the gene could be of
Stock taking stock of the latest advances in innovative treatments for lung cancer
Time of Update: 2020-06-03
90% of the disease control rate! One of the highlights of today's ASCO Annual Meeting of the first KRAS G12C inhibitors was undoubtedly the KRAS G12C inhibitor AMG 510 brought by Amgen This is also t
CollPlant completes $5.5 million financing to expand tissue organ 3D bioprinting business
Time of Update: 2020-06-02
CollPlant plans to use this round of funding to develop 3D bioprinting technology for use in medical beauty and organ transplantation it was reported that CollPlant had completed eight financings, wi